Condition

Lung Fibrosis Interstitial clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Lung Fibrosis Interstitial clinical trials that are recruiting, at sites in 3 countries (most in Italy (1), United States (1), Switzerland (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Lung Fibrosis Interstitial clinical trials

StudyPhaseWhereStatusRegistered
Remote monitoring to see if home spirometry, oximetry, scales, and surveys help track ILD — San Francisco, California Recruiting Jun 29, 2026
Pulmonary Fibrosis Learning and Self-Management Program (FILIP) for patients in rehab and outpatient care — Bern and 1 other locations Recruiting Mar 9, 2026
Evaluating inhalable Imatinib for treating pulmonary hypertension and lung fibrosis — Pavia, Pavia Recruiting Apr 8, 2025

All recruiting trials (3)

Related topics

Fibrotic Interstitial Lung DiseasePulmonary Arterial Hypertension (PAH)Imatinib

Quick answers

How many Lung Fibrosis Interstitial clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Italy (1 trial), United States (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.